Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 945-949, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldrich, J. T.
Right arrow Articles by Stevens, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldrich, J. T.
Right arrow Articles by Stevens, L. C.

Effect of 5-Fluorouracil on Early Teratomas in Mice1

John T. Aldrich and Leroy C. Stevens

The Jackson Laboratory, Bar Harbor, Maine 04609

Testicular teratomas were experimentally induced in Strain 129/Sv mice by grafting genital ridges from 12-day fetuses into the testes of adults. In approximately 80% of the grafts a teratocarcinogenetic process was initiated within 24 hr. The tumors grew and were composed predominantly of neural tissue. This provided a well-defined oncogenic system in which to study the carcinostatic effects of compounds such as 5-fluorouracil (FU). Host mice received a single injection of FU at 50 mg/kg on one of several days beginning with the day prior to grafting and ending with the 11th day following grafting. The development of teratomatous foci was markedly inhibited in grafts in mice treated on Days 1 through 6. Those in hosts treated on Days 7 through 11 had an increasing incidence of tumors approaching that of the controls (78%). FU at 25 mg/kg also prevented the growth of tumors when injected into host mice on Day 0 or Day 1.

1 Work carried out in partial fulfillment of the requirements for the M.D. degree, School of Medicine, Western Reserve University. This investigation was supported by Grants CA-02662 and CA-5013 from the USPHS, and by a grant from The John A. Hartford Foundation.

Received 8/ 3/66. Accepted 1/ 5/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.